The Employer Health Reckoning: What's Still Worth Paying For?

Employers are playing an increasingly significant role in how people access healthcare. From mental health and fertility to menopause, metabolic health, virtual care, and navigation, the range of health benefits available to employees has expanded significantly in recent years.

At the same time, healthcare costs continue to rise. GLP-1s and specialty medicines are creating new pressures on benefits budgets, while employers are being asked to invest in an ever-growing number of digital health solutions and preventative services. As budgets come under greater scrutiny, the question is shifting from which benefits employees want to which ones are actually delivering enough value to justify continued investment.

This is creating difficult decisions for benefits leaders. Utilization alone does not necessarily demonstrate impact, and improvements in employee health, productivity, retention, and long-term healthcare costs can be difficult to measure. Employers must determine which benefits are becoming essential, where evidence is strong enough to support investment, and where consolidation or a different approach may be needed.

This roundtable brings together employers, payers, benefits leaders, pharma, and digital health organizations to explore how the employer health landscape is evolving and what increasingly evidence-conscious buyers expect from the solutions they fund.

Join us to discuss:

• How are employers deciding which health benefits are genuinely worth paying for?

• What evidence and outcomes matter most when evaluating the value of a health benefit?

• How are rising costs across GLP-1s, specialty medicines, mental health, women's health, and other areas changing benefits strategies?

• Are employers moving away from individual point solutions towards more integrated approaches to employee health?